Skip to main content
EMBRACING FUTURE HOLDINGS LIMITED logo

EMBRACING FUTURE HOLDINGS LIMITED — Investor Relations & Filings

Ticker · 8YY ISIN · SGXE89830751 SGX Professional, scientific and technical activities
Open in API
Filings indexed 33 across all filing types
Latest filing 2025-04-14 AGM Information
Country SG Singapore
Listing SGX 8YY

About EMBRACING FUTURE HOLDINGS LIMITED

https://www.ebfholdings.com

Embracing Future Holdings Limited is a precision medicine medical technology company dedicated to developing innovative diagnostic solutions. A key offering is its patented Circulating Tumour Cell (CTC) enrichment system, designed for label-free separation of viable cancer cells from blood, which aims to lower healthcare costs and improve clinical outcomes. The company is also strategically diversifying its business model into technology-enabled lifestyle sectors, including Multi-Channel Networks, live streaming social e-commerce platforms, and Esports-related ventures, to build long-term growth.

Recent filings

Filing Released Lang Actions
Annual General Meeting::Voluntary
AGM Information Classification · 95% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' for Biolidics Limited, detailing the agenda for the AGM including adoption of audited financial statements, re-election of directors, approval of directors' fees, appointment of auditors, and authority to allot shares. It includes resolutions to be voted on at the AGM and explanatory notes about directors and share issuance authority. The document is a formal notice convening the AGM and does not contain the actual annual report or financial statements but references the Annual Report 2024 as already published and available elsewhere. The document length is about 15,000 characters, which is consistent with a detailed AGM notice but not a full annual report. Therefore, this document is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices and agendas.
2025-04-14 English
REPL::Annual General Meeting::Voluntary
AGM Information Classification · 100% confidence The document is titled 'NOTICE OF ANNUAL GENERAL MEETING' for Biolidics Limited, detailing the agenda for the AGM including adoption of audited financial statements, re-election of directors, approval of directors' fees, appointment of auditors, and authority to allot shares. It includes resolutions to be voted on at the AGM and explanatory notes about directors and share issuance authority. The document also provides logistical details about the meeting and proxy voting instructions. There is no actual financial data or report content, but rather a formal notice convening the AGM and outlining the business to be transacted. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including notices of meeting and agenda items. The document length is substantial (15,000 characters), consistent with a detailed AGM notice. Therefore, the correct classification is AGM Information (AGM-R).
2025-04-14 English
Financial Statements and Related Announcement::Discrepancies between unaudited and audited accounts
Audit Report / Information Classification · 95% confidence The document is an announcement by Biolidics Limited regarding material variances between the audited financial statements and the previously released unaudited financial statements for the financial year ended 31 December 2024. It references the upcoming 2024 Annual Report and the Independent Auditor's Report, but does not contain the full audited financial statements itself. The document provides detailed reconciliations and explanations of adjustments made by the independent auditor and management, including changes in share capital, goodwill, deferred tax liabilities, and cash flow statement classifications. The document is a regulatory announcement pursuant to SGX listing rules highlighting differences between unaudited and audited results, but it is not the full annual report or the auditor's standalone report. It is longer than 5,000 characters and contains substantive financial data and analysis, but it is primarily an explanatory announcement about the audited vs unaudited financials rather than the full annual report or audit report. Given the content and context, the best fitting classification is Audit Report / Information (AR), as it focuses on audit-related adjustments and reconciliations without being the full annual report (10-K) or just a brief announcement (RPA). FY 2024
2025-04-10 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.